Mitigating COVID-19 Risks in a Complex Pain Program: a Sponsor and CRO Perspective

UNITY Biotechnology partnered with Rho to execute a complex and fast-moving Osteoarthritis program with three concurrent clinical trials and database locks scheduled during the height of the COVID-19 pandemic. In this webinar, hear from both the Sponsor and CRO about the creative solutions they implemented and how they worked together to pivot quickly and meet critical study timelines in the midst of the pandemic. Topics in this webinar will include:

  • Challenges this team overcame during program execution
  • Real-world solutions to keep your program on-track during COVID-19
  • Insights for productive collaboration between Sponsors and CROs